{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:40:53Z","timestamp":1740138053947,"version":"3.37.3"},"reference-count":23,"publisher":"Portland Press Ltd.","issue":"6","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,3,31]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>In this commentary, we discuss new findings indicating that microbiota transplantation has favorable impact on portal hypertension (PH) in the experimental model of cirrhosis induced by bile duct ligation (BDL) (Huang et al.; Clin Sci (Lond) (2021) 135(24): 2709\u20132728, doi: 10.1042\/CS20210602). Sinusoidal PH is an ominous outcome of advanced chronic liver disease, characterized by increased intrahepatic vascular resistance (IHVR), splanchnic hyperemia, and the development of portosystemic collaterals. In the work of Huang et al., microbiota transplantation not only alleviated splanchnic hyperdynamic circulation by improving vascular responsiveness and decreasing mesenteric angiogenesis, but also reduced blood flow in portosystemic collaterals. Surprisingly, however, microbiota transplantation had no effect on intrahepatic vasoconstriction in this experimental model. We discuss these observations in the context of recent literature showing that manipulation of the gut microbiota (either by transplantation or through the use of probiotics) may improve IHVR, which is one of the earliest abnormalities in the pathogenesis of sinusoidal PH. Further research is needed to explore the specific molecular and cellular targets associated with the correction of dysbiosis in liver disease.<\/jats:p>","DOI":"10.1042\/cs20220029","type":"journal-article","created":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T12:39:35Z","timestamp":1648211975000},"page":"425-429","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Microbiota transplantation in portal hypertension: promises and pitfalls"],"prefix":"10.1042","volume":"136","author":[{"given":"Emilie\u00a0K.","family":"Mitten","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA, U.S.A."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8334-0400","authenticated-orcid":false,"given":"Gy\u00f6rgy","family":"Baffy","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA, U.S.A."},{"name":"Section of Gastroenterology, Department of Medicine, VA Boston Healthcare System, Boston, MA, U.S.A."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"288","published-online":{"date-parts":[[2022,3,25]]},"reference":[{"key":"2022032512374209700_B1","doi-asserted-by":"publisher","first-page":"S121","DOI":"10.1016\/j.jhep.2015.01.003","article-title":"Evolution in the understanding of the pathophysiological basis of portal hypertension: How changes in paradigm are leading to successful new treatments","volume":"62","author":"Bosch","year":"2015","journal-title":"J. Hepatol."},{"key":"2022032512374209700_B2","doi-asserted-by":"publisher","first-page":"S259","DOI":"10.1097\/MCG.0b013e318150d0e1","article-title":"Molecular mechanisms of increased intrahepatic resistance in portal hypertension","volume":"41","author":"Shah","year":"2007","journal-title":"J. Clin. Gastroenterol."},{"key":"2022032512374209700_B3","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.jhep.2007.02.006","article-title":"Vascular endothelial dysfunction in cirrhosis","volume":"46","author":"Iwakiri","year":"2007","journal-title":"J. Hepatol."},{"key":"2022032512374209700_B4","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41575-018-0097-3","article-title":"Hepatic microcirculation and mechanisms of portal hypertension","volume":"16","author":"Gracia-Sancho","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2022032512374209700_B5","doi-asserted-by":"publisher","first-page":"G980","DOI":"10.1152\/ajpgi.00336.2005","article-title":"Mild increases in portal pressure upregulate vascular endothelial growth factor and endothelial nitric oxide synthase in the intestinal microcirculatory bed, leading to a hyperdynamic state","volume":"290","author":"Abraldes","year":"2006","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"2022032512374209700_B6","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jhep.2010.03.021","article-title":"Hepatic endothelial dysfunction and abnormal angiogenesis: new targets in the treatment of portal hypertension","volume":"53","author":"Bosch","year":"2010","journal-title":"J. Hepatol."},{"key":"2022032512374209700_B7","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1016\/j.jhep.2020.11.013","article-title":"The microbiota in cirrhosis and its role in hepatic decompensation","volume":"75","author":"Trebicka","year":"2021","journal-title":"J. Hepatol."},{"key":"2022032512374209700_B8","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.jhep.2020.01.017","article-title":"Microbiota changes and intestinal microbiota transplantation in liver diseases and cirrhosis","volume":"72","author":"Bajaj","year":"2020","journal-title":"J. Hepatol."},{"key":"2022032512374209700_B9","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.jhep.2021.08.004","article-title":"Microbiome therapeutics for hepatic encephalopathy","volume":"75","author":"Bloom","year":"2021","journal-title":"J. Hepatol."},{"key":"2022032512374209700_B10","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s12072-017-9798-x","article-title":"Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg","volume":"12","author":"Arab","year":"2018","journal-title":"Hepatol. Int."},{"key":"2022032512374209700_B11","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1111\/liv.13986","article-title":"Potential mechanisms linking gut microbiota and portal hypertension","volume":"39","author":"Baffy","year":"2019","journal-title":"Liver Int."},{"key":"2022032512374209700_B12","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1042\/CS20210602","article-title":"Microbiota transplants from feces or gut content attenuated portal hypertension and portosystemic collaterals in cirrhotic rats","volume":"135","author":"Huang","year":"2021","journal-title":"Clin. Sci. (Lond.)"},{"key":"2022032512374209700_B13","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3390\/jcm10020330","article-title":"Gut microbiota modulation and fecal transplantation: an overview on innovative strategies for hepatic encephalopathy treatment","volume":"10","author":"Hassouneh","year":"2021","journal-title":"J. Clin. Med."},{"key":"2022032512374209700_B14","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.jhep.2014.05.047","article-title":"Vascular pathobiology in chronic liver disease and cirrhosis - current status and future directions","volume":"61","author":"Iwakiri","year":"2014","journal-title":"J. Hepatol."},{"key":"2022032512374209700_B15","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.jhep.2020.03.019","article-title":"Paneth cells promote angiogenesis and regulate portal hypertension in response to microbial signals","volume":"73","author":"Hassan","year":"2020","journal-title":"J. Hepatol."},{"key":"2022032512374209700_B16","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1007\/s00394-018-1709-y","article-title":"Improved hemodynamic and liver function in portal hypertensive cirrhotic rats after administration of B. pseudocatenulatum CECT 7765","volume":"58","author":"Gomez-Hurtado","year":"2019","journal-title":"Eur. J. Nutr."},{"key":"2022032512374209700_B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12072-017-9827-9","article-title":"The portal hypertension syndrome: etiology, classification, relevance, and animal models","volume":"12","author":"Bosch","year":"2018","journal-title":"Hepatol. Int."},{"key":"2022032512374209700_B18","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1440-1746.1996.tb00053.x","article-title":"Role of endotoxaemia in hyperdynamic circulation in rats with extrahepatic or intrahepatic portal hypertension","volume":"11","author":"Lee","year":"1996","journal-title":"J. Gastroenterol. Hepatol."},{"key":"2022032512374209700_B19","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.jhep.2017.05.007","article-title":"Targeting the gut-liver axis in liver disease","volume":"67","author":"Wiest","year":"2017","journal-title":"J. Hepatol."},{"key":"2022032512374209700_B20","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s10620-017-4903-5","article-title":"Origins of portal hypertension in nonalcoholic fatty liver disease","volume":"63","author":"Baffy","year":"2018","journal-title":"Dig. Dis. Sci."},{"key":"2022032512374209700_B21","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1097\/MPG.0b013e3181c7bdf1","article-title":"Endotoxin and plasminogen activator inhibitor-1 serum levels associated with nonalcoholic steatohepatitis in children","volume":"50","author":"Alisi","year":"2010","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"2022032512374209700_B22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1476-9255-7-15","article-title":"Elevated endotoxin levels in non-alcoholic fatty liver disease","volume":"7","author":"Harte","year":"2010","journal-title":"J. Inflamm."},{"key":"2022032512374209700_B23","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1002\/hep.29646","article-title":"Restoration of a healthy intestinal microbiota normalizes portal hypertension in a rat model of nonalcoholic steatohepatitis","volume":"67","author":"Garcia-Lezana","year":"2018","journal-title":"Hepatology"}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/136\/6\/425\/931295\/cs-2022-0029c.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/136\/6\/425\/931295\/cs-2022-0029c.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T12:39:37Z","timestamp":1648211977000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/136\/6\/425\/231074\/Microbiota-transplantation-in-portal-hypertension"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,3,31]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20220029","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"type":"print","value":"0143-5221"},{"type":"electronic","value":"1470-8736"}],"subject":[],"published-other":{"date-parts":[[2022,3]]},"published":{"date-parts":[[2022,3]]}}}